KEARNY, NJ (May 21, 2008) -- Proprietary Nutritionals Inc. (PNI) announced that the International Federation of Sports Medicine (FIMS) and its Executive Committee has selected Celadrin® Topical Cream as its Official Pain Relieving Cream. FIMS’s goal since 1928 has been to provide the best medical care for the athletes of the summer and winter Olympic Games. Now it has expanded its goal to provide the most advanced knowledge and technologies in sports medicine for world class athletes and exercise enthusiasts.
“The fact that Celadrin® was selected by this world class organization demonstrates complete confidence in its efficacy,” said Dean Mosca, president of PNI, marketer of Celadrin. “FIMS consists of national associations of top sports medicine physicians, specialists and researchers and their endorsement is indicative of the strong science surrounding the product and the effective results the product has produced in athletes,”.
Celadrin® has been endorsed by FIMS as the official pain relieving cream for a period encompassing the years 2008 until 2012. Celadrin® will maintain this exclusive and prestigious association throughout this athletic cycle.
Dr. Walter Frontera, the president of FIMS, stated that “FIMS is very impressed with the scientifically validated Celadrin® Topical Pain Cream. After reviewing the scientific attributes of Celadrin® Topical Pain Cream, FIMS is convinced of its efficacy for the treatment of soft tissue injuries that may interfere with sports performance.”
Mosca added, “The highly compelling scientific data from clinical trials showing reduced joint discomfort and inflammation was key to their recommendation. We believe this endorsement will be instrumental in the retail launch of our branded product and will be the cornerstone of an advertising program utilizing testimonials of athletes alike who use and endorse the product.”
The Fédération Internationale de Médecine du Sports (FIMS)/International Federation of Sports Medicine is an international organization comprised of individual members, national associations, and multinational groups, with a common involvement with sports medicine on all continents. FIMS aims primarily to promote the study and development of sports medicine throughout the world, to assist athletes in achieving optimal performance, and to enhance health through the practice of exercise and physical activity in the general population. www.fims.org.
Proprietary Nutritionals, Inc., a subsidiary of Pharmachem Laboratories, Inc., is located in Kearny, New Jersey, USA. PNI markets Celadrin® Joint Flexibility & Relief, and other patented, scientifically proven, branded ingredients to the nutraceuticals industry. For further information, visit www.celadrininfo.com or call 519/647-2071.
This document contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements are subject to risks and uncertainties that could cause actual results to vary materially from those projected in the forward-looking statements. The company may experience significant fluctuations in future operating results due to a number of economic, competitive, and other factors, including, among other things, the size and timing of customer contracts, new or increased competition, changes in market demand, and seasonality of purchases of the company's products and services. These factors and others could cause operating results to vary significantly from those in prior periods and those projected in forward-looking statements. Additional information with respect to these and other factors, which could materially affect the company and its operations, are included in certain forms the company has filed and will periodically file with the Securities Exchange Commission.